▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Pluto Bio Raises $3.6M to Expand AI-Powered Multi-Omics Analysis Platform for Pharma

#bioinformatics--Pluto Bio, the leading, AI-powered platform for computational biology, today announced it has raised $3.6 million in new funding to accelerate growth and scale adoption of its enterpr...

Business Wire

Funding led by new investor Kickstart, with continued support from Silverton Partners and other investors

DENVER: #bioinformatics--Pluto Bio, the leading, AI-powered platform for computational biology, today announced it has raised $3.6 million in new funding to accelerate growth and scale adoption of its enterprise-grade platform among global pharma companies. The round includes participation from new investor Kickstart, alongside existing investor Silverton Partners and existing angel investors.

Pluto’s platform serves as the industry’s most powerful "canvas for computational biology" – a secure, collaborative environment where scientists at therapeutics companies explore large, high-dimensional datasets, run auto-scaling bioinformatics pipelines, and generate publication-ready visualizations tailored to their specific scientific questions without writing code. As large language models (LLMs) reshape drug discovery and development, Pluto is at the forefront of empowering biology and translational medicine teams to harness AI in a manner that complements the vital insights from human scientists.

“AI is transforming how we interrogate biology,” said Dalton Wright, General Partner at Kickstart. “What impressed us about Pluto is how it puts the power of LLMs into the hands of domain expert scientists – biologists, translational researchers, and discovery teams – by giving them an instantly intuitive interface for expressing scientific questions faster and in a way that increases scientific rigor and reproducibility.”

Pluto enables scientists to run proprietary analyses on both public datasets – such as The Cancer Genome Atlas (TCGA), Cancer Cell Line Encyclopedia (CCLE), and Gene Expression Omnibus (GEO) – and internal, raw data using industry-validated, auto-scaling pipelines built for scale, security, and reproducibility. Scientists use Pluto for critical steps in early-mid drug discovery, such as target discovery, mechanism of action (MoA) studies, translational medicine, and biomarkers/precision medicine research. The platform supports the wide range of assays used for investigating targets and biomarkers, including genomics, transcriptomics, epigenetics, and proteomics.

The platform is trusted by mid-market and enterprise clients across North America and Europe, with users spanning discovery biology, translational research, and computational teams. As a collaborative layer over drug discovery data infrastructure, Pluto integrates seamlessly into existing scientific workflows and supports data governance needs for regulated environments.

“With this funding, we’re fueling our mission to make high-dimensional biological data accessible to the people who deeply understand the underlying biology and unmet therapeutic needs,” said Dr. Rani Powers, Founder and CEO of Pluto. “Teams using Pluto are already demonstrating that innovation in drug discovery accelerates when scientists can directly generate insights from complex data. Our platform was built to make that vision real, whether for a team of ten scientists or an enterprise organization with hundreds.”

The new capital will support continued development of Pluto’s AI agents and copilots, expansion of integrations with other R&D tools, enable build-out of commercial roles, and accelerate deployment across therapeutic areas and modalities.

About Pluto

Pluto Bio is the leading AI-powered data management, analysis, and visualization platform for multi-omics. Designed for pharma, Pluto enables scientists to analyze, visualize, and collaborate on large-scale biological data without writing code. From target discovery to translational medicine, Pluto empowers R&D and translational science teams to turn complex datasets into insights faster and with greater confidence. Learn more at pluto.bio.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

AI Strengthening Cybersecurity Software, ISG Says

$III #AI--Growing and evolving security threats make it increasingly important for enterprises to deploy advanced cybersecurity software and to understand…

Mitsubishi Electric’s ME Innovation Fund Invests in AI-assisted PLM Systems…

Mitsubishi Electric Corporation (TOKYO: 6503) announced today that its ME Innovation Fund has invested in Things, Inc., a Japan-based startup that develops…

Team8 Expands Cyber and AI Focus with New Partner Appointments, Ori Barzilay…

Team8 a global venture fund that builds and invests in companies across cybersecurity, data, AI, fintech, and digital health, as well as their intersections…

PropStream Announces Acquisition of Batch Leads and Batch Dialer, Enhancing…

#BrianTepfer--PropStream, a leading real estate data and analytics platform and company in the Stewart Information Services Corporation family of companies…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!